NantHealth to Present at the Bank of America Merrill Lynch Health Care Conference 2018 on May 17
May 17, 2018
CULVER CITY, Calif.--(BUSINESS WIRE)--
NantHealth, Inc. (NASDAQ-GS: NH), a next-generation, evidence-based,
personalized healthcare company, today announced that its management
will be presenting at the Bank of America Merrill Lynch 2018 Health Care
Conference on Thursday, May 17, 2018, at 11:20 a.m. PT in Las Vegas.
About NantHealth, Inc.
NantHealth, Inc., a member of the NantWorks ecosystem of companies, is a
next-generation, evidence-based, personalized healthcare company
enabling improved patient outcomes and more effective treatment
decisions for critical illnesses. NantHealth's unique systems-based
approach to personalized healthcare applies novel diagnostics tailored
to the specific molecular profiles of patient tissue and integrates this
molecular data in a clinical setting with large-scale, real-time
biometric signal and phenotypic data to track patient outcomes and
deliver precision medicine. For nearly a decade, NantHealth has
developed an adaptive learning system that integrates our unique
molecular profiling solution, software and hardware. Our system
infrastructure collects, indexes, analyzes and interprets billions of
molecular, clinical, operational and financial data points derived from
novel and traditional sources to continuously improve decision-making
and optimize our clinical pathways and decision algorithms over time.
For more information please visit www.nanthealth.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20180516006642/en/
NantHealth, Inc.
Investor Contact:
Robert Jaffe, 424.288.4098
rjaffe@rjaffeco.com
Source: NantHealth, Inc.